Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Segment Operations
MCK logo

McKesson Hits Record $403.4 Billion Revenue Driven by 31% Surge in Oncology Segment

MCK10-KFiling Date: 5/8/2026
McKesson Corporation
Description

What this story covers

McKesson Corporation achieved record revenues of $403.4 billion in fiscal 2026, fueled by strategic shifts toward oncology and pharmaceutical technology. Despite legal and regulatory challenges, the company returned $5.1 billion to shareholders while streamlining operations through major divestitures.

Story snapshot

CompanyMcKesson Corporation
TickerMCK
VariantStandard detailed
Duration12:02
Filing type10-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0000927653-26-000069
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in